Variant report

Variant	nsv883313
Chromosome Location	chr6:154536-183900
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:157406-157408	K562	blood:	n/a	n/a
2	ARID3A	chr6:168940-169157	HepG2	liver:	n/a	n/a
3	ATF2	chr6:181000-181701	GM12878	blood:	n/a	n/a
4	ATF2	chr6:154275-155106	GM12878	blood:	n/a	n/a
5	ATF2	chr6:181047-181898	GM12878	blood:	n/a	n/a
6	ATF2	chr6:154306-155179	GM12878	blood:	n/a	n/a
7	ATF2	chr6:156670-157032	GM12878	blood:	n/a	n/a
8	BATF	chr6:183781-184092	GM12878	blood:	n/a	n/a
9	BATF	chr6:156683-156991	GM12878	blood:	n/a	n/a
10	BATF	chr6:156491-157009	GM12878	blood:	n/a	n/a
11	BATF	chr6:154252-155133	GM12878	blood:	n/a	n/a
12	BATF	chr6:181320-181669	GM12878	blood:	n/a	n/a
13	BATF	chr6:154691-155030	GM12878	blood:	n/a	n/a
14	BATF	chr6:181382-181622	GM12878	blood:	n/a	n/a
15	BATF	chr6:154197-154629	GM12878	blood:	n/a	n/a
16	BCL11A	chr6:181394-181586	GM12878	blood:	n/a	chr6:181481-181490
17	BCL11A	chr6:156702-156991	GM12878	blood:	n/a	n/a
18	BCL11A	chr6:154309-155065	GM12878	blood:	n/a	n/a
19	BCL11A	chr6:156633-157058	GM12878	blood:	n/a	n/a
20	BCL3	chr6:154271-155009	GM12878	blood:	n/a	n/a
21	BCL3	chr6:155810-156195	GM12878	blood:	n/a	n/a
22	BCL3	chr6:154627-155012	GM12878	blood:	n/a	n/a
23	BCL3	chr6:181242-181640	GM12878	blood:	n/a	chr6:181481-181490
24	BCLAF1	chr6:181165-181751	GM12878	blood:	n/a	chr6:181481-181490
25	BCLAF1	chr6:154574-155179	GM12878	blood:	n/a	n/a
26	BHLHE40	chr6:181240-181647	GM12878	blood:	n/a	n/a
27	BRCA1	chr6:181184-181190	GM12878	blood:	n/a	n/a
28	CEBPB	chr6:167113-167409	Hela-S3	cervix:	n/a	chr6:167228-167239
29	CEBPB	chr6:167215-167379	H1-hESC	embryonic stem cell:	n/a	chr6:167228-167239
30	CEBPB	chr6:175194-175390	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr6:167122-167477	K562	blood:	n/a	chr6:167228-167239
32	CEBPB	chr6:167170-167315	A549	lung:	n/a	chr6:167228-167239
33	CEBPB	chr6:167108-167420	HepG2	liver:	n/a	chr6:167228-167239
34	CEBPB	chr6:174130-174338	HepG2	liver:	n/a	chr6:174244-174255
35	CEBPB	chr6:168881-169126	HepG2	liver:	n/a	n/a
36	CEBPB	chr6:180266-180564	K562	blood:	n/a	n/a
37	CEBPB	chr6:168922-169138	A549	lung:	n/a	n/a
38	CEBPB	chr6:168835-169203	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr6:154313-155156	GM12878	blood:	n/a	n/a
40	CEBPB	chr6:167167-167294	K562	blood:	n/a	chr6:167228-167239
41	CEBPB	chr6:168881-169187	K562	blood:	n/a	n/a
42	CTCF	chr6:168768-169419	HCT-116	colon:	n/a	chr6:169060-169078 chr6:168807-168815 chr6:169061-169077 chr6:169055-169076 chr6:169065-169073
43	CTCF	chr6:157340-157490	HFF	foreskin:	n/a	chr6:157340-157353 chr6:157342-157350
44	CTCF	chr6:168981-169165	MCF-7	breast:	n/a	chr6:169060-169078 chr6:169061-169077 chr6:169055-169076 chr6:169065-169073
45	CTCF	chr6:168895-169182	A549	lung:	n/a	chr6:169060-169078 chr6:169061-169077 chr6:169055-169076 chr6:169065-169073
46	CTCF	chr6:157280-157430	HPAF	blood vessel:	n/a	chr6:157340-157353 chr6:157342-157350 chr6:157339-157360 chr6:157338-157354 chr6:157337-157355
47	CTCF	chr6:157280-157430	HepG2	liver:	n/a	chr6:157340-157353 chr6:157342-157350 chr6:157339-157360 chr6:157338-157354 chr6:157337-157355
48	CTCF	chr6:169020-169170	NHLF	lung:	n/a	chr6:169060-169078 chr6:169061-169077 chr6:169055-169076 chr6:169065-169073
49	CTCF	chr6:168980-169130	GM12871	blood:	n/a	chr6:169060-169078 chr6:169061-169077 chr6:169055-169076 chr6:169065-169073
50	CTCF	chr6:157260-157441	HepG2	liver:	n/a	chr6:157340-157353 chr6:157342-157350 chr6:157339-157360 chr6:157338-157354 chr6:157337-157355

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:179659-179709	HMEC	breast:	n/a
2	chr6:179659-179709	HCF	heart:	n/a
3	chr6:179659-179709	IMR90	lung:	fetal
4	chr6:179456-179506	U87	brain:	n/a
5	chr6:179456-179506	BE2_C	brain:	n/a
6	chr6:179456-179506	HCM	heart:	n/a
7	chr6:179456-179506	NHBE	bronchial:	n/a
8	chr6:179659-179709	Jurkat	blood:	n/a
9	chr6:179659-179709	HPAEpiC	pulmonary alveolar:	n/a
10	chr6:179659-179709	GM19239	blood:	n/a
11	chr6:179456-179506	T-47D	breast:	n/a
12	chr6:179456-179506	HRE	kidney:	n/a
13	chr6:179659-179709	ProgFib	skin:	n/a
14	chr6:179659-179709	U87	brain:	n/a
15	chr6:179456-179506	HUVEC	blood vessel:	n/a
16	chr6:179659-179709	SAEC	small airway:	n/a
17	chr6:179659-179709	GM12892	blood:	n/a
18	chr6:179659-179709	ovcar-3	ovarian:	n/a
19	chr6:179456-179506	AG09319	gingival:	n/a
20	chr6:179659-179709	K562	blood:	n/a
21	chr6:179456-179506	MCF-7	breast:	n/a
22	chr6:179456-179506	NT2-D1	testis:	n/a
23	chr6:179456-179506	PFSK-1	brain:	n/a
24	chr6:179659-179709	HRPEpiC	eye:	n/a
25	chr6:179456-179506	AG09309	skin:	n/a
26	chr6:179456-179506	Caco-2	colon:	n/a
27	chr6:179456-179506	IMR90	lung:	fetal
28	chr6:179456-179506	ovcar-3	ovarian:	n/a
29	chr6:179659-179709	Hela-S3	cervix:	n/a
30	chr6:179456-179506	CMK	blood:	n/a
31	chr6:179456-179506	NB4	blood:	n/a
32	chr6:179659-179709	HUVEC	blood vessel:	n/a
33	chr6:179659-179709	HL-60	blood:	n/a
34	chr6:179456-179506	GM12892	blood:	n/a
35	chr6:179659-179709	NH-A	brain:	n/a
36	chr6:179659-179709	GM06990	blood:	n/a
37	chr6:179659-179709	HEK293	kidney:	embryo
38	chr6:179456-179506	HCF	heart:	n/a
39	chr6:179659-179709	RPTEC	kidney:	n/a
40	chr6:179659-179709	Caco-2	colon:	n/a
41	chr6:179659-179709	HIPEpiC	eye:	n/a
42	chr6:179456-179506	A549	lung:	n/a
43	chr6:179456-179506	NH-A	brain:	n/a
44	chr6:179659-179709	ECC-1	luminal epithelium:	n/a
45	chr6:179659-179709	HepG2	liver:	n/a
46	chr6:179659-179709	PFSK-1	brain:	n/a
47	chr6:179456-179506	Hela-S3	cervix:	n/a
48	chr6:179659-179709	HCM	heart:	n/a
49	chr6:179456-179506	HEK293	kidney:	embryo
50	chr6:179659-179709	AG09309	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:29168..29759-chr6:156896..157405,3	MCF-7	breast:
2	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
3	chr4:28899..29522-chr6:156896..157400,2	MCF-7	breast:
4	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
5	chr6:182386..184733-chr6:187298..189526,2	K562	blood:
6	chr6:174671..177385-chr6:182024..184445,2	K562	blood:
7	chr6:181320..184707-chr6:184919..187235,3	K562	blood:
8	chr6:174671..177385-chr6:182024..184445,2	K562	blood:
9	chr6:181397..184733-chr6:185247..188798,3	K562	blood:
10	chr6:181476..184276-chr6:186622..188907,2	MCF-7	breast:
11	chr6:162155..164910-chr6:167837..169506,2	K562	blood:
12	chr6:162155..164910-chr6:167837..169506,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EXOC2-20	chr6:168171-170561	NONHSAT105972
2	lnc-AL035696.1-6	chr6:169950-170088	NONHSAT105973
3	lnc-AL035696.1-5	chr6:155135-155395	XLOC_005116
4	lnc-AL035696.1-5	chr6:156119-156514	XLOC_005116
5	lnc-EXOC2-20	chr6:167607-167826	NONHSAT105971
6	lnc-EXOC2-20	chr6:169545-169753	NONHSAT105971
7	lnc-EXOC2-20	chr6:170352-170631	NONHSAT105971
8	lnc-EXOC2-6	chr6:181466-181695	ENSG00000263667.1
9	lnc-EXOC2-20	chr6:171827-172220	NONHSAT105972
10	lnc-EXOC2-6	chr6:182366-182474	ENSG00000263667.1
11	lnc-AL035696.1-6	chr6:171079-171400	NONHSAT105973
12	lnc-AL035696.1-6	chr6:170686-171068	NONHSAT105973
13	lnc-AL035696.1-5	chr6:156546-156639	XLOC_005116

Variant related genes	Relation type
ENSG00000218577	TF binding region
ENSG00000218577	CpG island

Extended variants
information (count: 375 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:375 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs114520107	chr6:154536-154537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs112464760	chr6:154567-154568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs113038791	chr6:154579-154580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs12524398	chr6:154694-154695	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs545744117	chr6:154738-154739	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs199991391	chr6:154749-154750	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs10484790	chr6:154750-154751	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs112970298	chr6:154788-154789	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs62388683	chr6:154801-154802	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs111545221	chr6:154846-154847	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs372936224	chr6:155212-155213	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
12	rs377224765	chr6:155432-155433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs148337345	chr6:155577-155578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs376960544	chr6:155578-155579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs554239991	chr6:155601-155602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs369981620	chr6:155685-155686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs115670676	chr6:155815-155816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs374495145	chr6:155941-155942	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs556551440	chr6:155975-155976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs35385584	chr6:156003-156004	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs542002353	chr6:156025-156026	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs555580085	chr6:156034-156035	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs562550261	chr6:156062-156063	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs572310529	chr6:156096-156097	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs116072078	chr6:156100-156101	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs371271036	chr6:156131-156132	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
27	rs531984318	chr6:156135-156136	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
28	rs372494423	chr6:156142-156143	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
29	rs377061905	chr6:156151-156152	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
30	rs531680063	chr6:156160-156161	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
31	rs565884913	chr6:156161-156162	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
32	rs113563289	chr6:156182-156183	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
33	rs369061401	chr6:156186-156187	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
34	rs541394626	chr6:156190-156191	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
35	rs371361984	chr6:156192-156193	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
36	rs376539712	chr6:156201-156202	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
37	rs41302901	chr6:156211-156212	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
38	rs377721708	chr6:156217-156218	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
39	rs371386809	chr6:156221-156222	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
40	rs570944175	chr6:156294-156295	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
41	rs200401345	chr6:156321-156322	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs373637098	chr6:156451-156452	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs371898365	chr6:156512-156513	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs367606315	chr6:156532-156533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs112862762	chr6:156669-156670	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs201155724	chr6:156874-156875	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs371974523	chr6:156975-156976	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs111602870	chr6:156985-156986	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs184886638	chr6:157123-157124	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs368141439	chr6:157199-157200	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Autism	22495311	CNVD
small cell lung cancer	20016488	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Prostate cancer	18632612	CNVD

Chromatin state (count:97 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:151800-155200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr6:151800-155600	Enhancers	HMEC	breast
3	chr6:153000-155000	Enhancers	NHEK	skin
4	chr6:153400-154800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
5	chr6:153600-154600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr6:153800-157400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr6:154000-155800	Weak transcription	Fetal Thymus	thymus
8	chr6:154000-157000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr6:154200-154600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr6:154200-155000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr6:154200-156200	Weak transcription	NHDF-Ad	bronchial
12	chr6:154400-154600	Enhancers	GM12878-XiMat	blood
13	chr6:154400-156200	Weak transcription	Thymus	Thymus
14	chr6:154600-155000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr6:154600-155200	Flanking Active TSS	GM12878-XiMat	blood
16	chr6:154600-155200	Enhancers	Osteobl	bone
17	chr6:154600-156200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr6:155000-155200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr6:155000-155200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
20	chr6:155000-155200	Enhancers	NHLF	lung
21	chr6:155200-156200	Weak transcription	NHLF	lung
22	chr6:155200-156400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr6:155200-156600	Weak transcription	Osteobl	bone
24	chr6:155200-157000	Enhancers	GM12878-XiMat	blood
25	chr6:155600-156000	Weak transcription	HMEC	breast
26	chr6:155600-158000	Enhancers	Adipose Nuclei	Adipose
27	chr6:155800-158000	Enhancers	Fetal Thymus	thymus
28	chr6:156000-156200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
29	chr6:156000-157600	Enhancers	HMEC	breast
30	chr6:156200-156400	Enhancers	Thymus	Thymus
31	chr6:156200-157000	Enhancers	NHLF	lung
32	chr6:156200-157200	Enhancers	NHDF-Ad	bronchial
33	chr6:156200-157400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr6:156400-156800	Weak transcription	Thymus	Thymus
35	chr6:156400-157000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr6:156800-157000	Enhancers	Osteobl	bone
37	chr6:156800-157600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
38	chr6:156800-157600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
39	chr6:156800-157600	Enhancers	Thymus	Thymus
40	chr6:157000-157200	Flanking Active TSS	GM12878-XiMat	blood
41	chr6:157200-157400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
42	chr6:157200-157400	Enhancers	GM12878-XiMat	blood
43	chr6:157400-157600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr6:157400-157600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr6:157400-157600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
46	chr6:157400-157600	Flanking Active TSS	GM12878-XiMat	blood
47	chr6:157600-158800	Enhancers	GM12878-XiMat	blood
48	chr6:158000-158400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
49	chr6:165600-167000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr6:165800-167000	Enhancers	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links